Graham Capital Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $335K | Buy |
2,435
+256
| +12% | +$35.2K | 0.01% | 919 |
|
|
2025
Q1 | $393K | Buy |
2,179
+97
| +5% | +$17.5K | 0.01% | 873 |
|
|
2024
Q4 | $326K | Sell |
2,082
-149
| -7% | -$23.3K | ﹤0.01% | 868 |
|
|
2024
Q3 | $406K | Sell |
2,231
-148
| -6% | -$26.9K | 0.01% | 663 |
|
|
2024
Q2 | $437K | Buy |
+2,379
| New | +$437K | 0.01% | 599 |
|
|
2023
Q4 | – | Sell |
-2,849
| Closed | -$330K | – | 1148 |
|
|
2023
Q3 | $330K | Buy |
+2,849
| New | +$330K | 0.01% | 676 |
|